Rivaroxaban Plus Aspirin Cuts Stroke Rate in Half Rivaroxaban Plus Aspirin Cuts Stroke Rate in Half

New results from the COMPASS trial show combination therapy reduced the ischemic stroke rate by 49% vs aspirin alone in patients with stable vascular disease, without increasing intracerebral bleeding.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news